Skip to main content
Log in

Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The aim was to investigate factors associated with depression and social function, two outcomes identified as important by people with multiple sclerosis (MS) and to identify underlying dimensions of psycho-social well-being that may be useful as outcome measures. People with MS in eight randomly selected health authorities/boards in England and Scotland completed a postal questionnaire relating to preferences and needs for their health and social care, along with the Beck Depression Inventory and the SF-36. Responses to 10 of the original items were subjected to factor analysis. These and other explanatory variables were entered into multivariable regression models for the two outcomes. The factor analysis resulted in three dimensions representing different aspects of psycho-social well-being; one of these (representing autonomy) was associated with improvements in both outcomes, as was the SF-36 emotional role limitation score. Three other SF-36 dimensions and lack of contact with a health professional in the last year were related just to social function. The regression models emphasise the value of enabling autonomy and self-reliance amongst people with MS, as well as more general measures of emotional health. The present work identifies specific questions that could be used to measure pivotal aspects of an individual's psycho-social well-being. While these findings warrant replication for people with MS, they may have relevance to those with other long-term illnesses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Vercoulen JHMM, Hommes OR, Swanink CMA, et al. The measurement of fatigue in patients with multiple sclerosis. Arch Neurol 1996; 53: 642–649.

    Google Scholar 

  2. Scott T, Allen D, Price T, McConnell H, Lang D. Characterization of major depression symptoms in multiple sclerosis patients. J Neuropsychiat 1996; 8: 318–323.

    Google Scholar 

  3. Barak Y, Kimhi R, Bodner E, Achiron A. Treatment of depression in patients with multiple sclerosis. The Neurol 1998; 4: 99–104.

    Google Scholar 

  4. Freeman A, Thompson AJ. Community services in multiple sclerosis: Still a matter of chance. J Neurol Neurosur Psychiat 2000; 69: 728–732.

    Google Scholar 

  5. Levenson R, Joule N. Improving People's Lives: The Agenda for People with Long-Term Medical Conditions. LMCA, 1999.

  6. Somerset M, Sharp D, Campbell R. Multiple sclerosis and quality of life: The development of a framework by which to identify needs. J Health Serv Res Policy (in press).

  7. Somerset M, Campbell R, Sharp DJ, Peters TJ. What do people with MS want and expect from health-care services? Health Expectations 2001; 4: 29–37.

    Google Scholar 

  8. Mohr D, Goodkin D, Likosky W, Beutler L, Gatto N, Langan M. Identification of Beck depression inventory items related to multiple sclerosis. J Behav Med 1997; 20: 190–197.

    Google Scholar 

  9. Hakim EA, Bakheit AM, Byrant TN, et al. The social impact of multiple sclerosis-a study of 302 patients and their relatives. Disabil Rehabil 2000; 22(6): 288–293.

    Google Scholar 

  10. Ware J, Snow K, Kosinski M, Gandek B. Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Centre, 1993; 6–22.

    Google Scholar 

  11. Freeman JA, Hobart JC, Langdon DW. Clinical appropriateness: A key factor in outcome measure selection; the SF-36 item short form health survey in multiple sclerosis: J Neurol Neurosurg Psychiat 2000; 68: 150–156.

    Google Scholar 

  12. Freeman JA, Hobart JC, Thompson, AJ. Does adding MSspecific items to the generic measure (the SF-36) improve measurement? Neurology 2001; 57: 68–74.

    Google Scholar 

  13. Beck A, Beamesderfer A. Assessment of depression: The Depression Inventory. Pharmacopsychiatry 1974; 7: 151–169.

    Google Scholar 

  14. Streiner D, Norman G. Health Measurement Scales. Oxford: Oxford Medical Publications, 1993.

    Google Scholar 

  15. Stata Corp. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation, 1999.

    Google Scholar 

  16. Antonak RF, Livneh H. A hierarchy of reactions to disability. Int J Rehabil Res 1991; 14: 13–24.

    Google Scholar 

  17. Hainsworth M. Living with multiple sclerosis. J Neurosci Nurs 1994; 26: 237–240.

    Google Scholar 

  18. WHOQOL. Measuring Quality of Life. The Development of the World Health Organisation Quality of Life Instrument (WHOQOL). Geneva: WHO Division of Mental Health, 1993.

    Google Scholar 

  19. Shnek Z, Foley F, LaRocca N. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med 1997; 19: 287–294.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Somerset, M., Peters, T.J., Sharp, D.J. et al. Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Qual Life Res 12, 21–29 (2003). https://doi.org/10.1023/A:1022088203586

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022088203586

Navigation